About US
Contact us
-
FiercePharmaPolitics—Lawmakers, Americans weigh merits of House and Senate pricing billsWelcome to theFiercePharmapolitical roundup, where each Monday we’ll highlight developments in Washington, D.C., and elsewherethat could affect howdrugmakersoperate. As lawmakers continue to debatedr2019/11/1
-
Daiichi Sankyo pulls out of U.S. pain market amid oncology pivot, opioid scrutinyDaiichi Sankyo’s short-lived interest in the U.S. pain management market has officially come to an end, as the company's new CEOcontinues shifting its focus to oncology and the industry reels from th2019/11/1
-
FDA: Zantac carcinogens no more dangerous than 'grilled or smoked meats'Drugmakers may be recalling theheartburn med Zantac around the world, but the FDA wants consumers to stop worrying. Higher-than-recommended levelsof a possiblecarcinogenin the pills are no more dange2019/10/31
-
J&J taps kidney specialist Vifor for Invokana marketing helpJohnson & Johnson scored a one-of-a-kind win for SGLT2 med Invokana in September with an FDA approval to treat kidney disease. Now, as a newcomer to the field, J&J is seeking an experienced h2019/10/31
-
Lilly, BI's Jardiance still beats Novo's Rybelsus when it comes to cost-effectiveness: ICERThe Institute for Clinical and Economic Review (ICER) started giving Novo Nordisk a hard time about the cost-effectiveness of its oral version of semaglutide, Rybelsus, before the drug was even appro2019/10/30
-
Novartis' Cosentyx can't top AbbVie's Humira in head-to-head psoriatic arthritis contestEli Lilly’s Taltz and Novartis’ Cosentyx have been battling it out lately in the next-gen psoriatic arthritis field. But Lilly’s drug has a big win under its belt that Novartis can’t tout. Friday, th2019/10/30
-
Is AbbVie's Imbruvica concerned about AZ's rising Calquence? We've got this covered, execs sayAbbVie has a lot on its plate with a megamerger with Allergan in the works and the rollout of blockbuster hopeful Rinvoq. One thing it hasn't hadto worry about much is its blood cancer franchise––and2019/10/29
-
Novo preps for Rybelsus 'strike mode' as Ozempic hits blockbuster heightsNovo Nordisk's oral GLP-1Rybelsus rollout isn't yet showing up on its earnings reports, but, behind the scenes, the drugmaker is busy mapping out its key launch. The med, a follow-up to Novo'solder V2019/10/29
-
WuXi STA’s Jinshan Facility Passes EMA InspectionOctober 28, 2019: STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announced today that its Jinshan manufacturing facility in Shanghai, China has successfully passed an inspect2019/10/28
-
Merck to lay off 500 workers around the U.S. in continued shift to innovative medsMerck, like many of its Big Pharma peers,is working to focus more on innovative drugs. But as part of that ongoing shift, the company is eliminating 500 positions nationwide. The company is cuttingjo2019/10/28